This federal contract award, valued at $4,042.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of MEKINIST 0.05 MG/ML SOLUTION 90ML, a pharmaceutical product, with an ultimate completion date of October 31, 2024. This is a firm fixed-price delivery order contract, and there was no set-aside designation used. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price pricing type and a Ceiling Value of $4,460.92. The contract was awarded by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product MEKINIST 0.05 MG/ML SOLUTION 90ML. The contract has an Ultimate Completion Date of June 30, 2025 and was awarded on June 6, 2025. The contract is not designated as a Set-Aside. Amerisourcebergen Drug...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,589.70 for the provision of MEKINIST 0.5 MG TABLET medical products. The award was made on June 6, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 28, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,468.49, is for the delivery of the drug MEKINIST 2 MG TABLET in 30-tablet units. This is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which has a ceiling value of up to $999,999,999 and runs through December 2025. The contract does...
This federal contract award is for the delivery of MEKINIST 0.5 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,589.70, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $19,341.02, is a delivery order for the supply of 4567490486 MEKINIST 2 MG TABLET UU 30S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4565091381 MEKINIST 0.5 MG TABLET UU 30S. The contract has a ceiling value of $2,589.70 and an ultimate completion date of July 29, 2024. It is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FHA11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,589.70 firm-fixed-price delivery order is for the supply of 4564491290 - MEKINIST 0.5 MG TABLET UU 30S, with an ultimate completion date of May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MEKINIST 0.05 MG/ML SOLUTION 90ML, a pharmaceutical product. The award has a ceiling value of $4,042.76 and a performance period through April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,341.02 firm fixed-price delivery order is for the supply of 4,568,131,488 units of the medication MEKINIST 2MG TAB 30S. The contract has an ultimate completion date of May 27, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...